Quick. Efficient. Optimized.

Smarter Rapid Drug Testing with eCup™+

HOW ARE MANUAL COLLECTION PROCESSES IMPACTING YOUR CLINIC'S PRODUCTIVITY?

TIME IS MONEY

Managing paper-based collection processes and multiple device SKUs for rapid urine drug testing can significantly reduce your clinic’s operational efficiency and impact your revenue.

Those challenges can also have a downstream impact on your clients, who depend on you for fast, efficient drug screen results for non-federal / non-DOT testing, so they can retain their first-choice job candidates and minimize potential workforce downtime.​

For comparison, the negative impact of manual, paper-based processes on the U.S. healthcare industry is well‑documented. ​

DON’T WASTE YOUR VALUABLE TIME

The innovative technology of the patented eCup™+ rapid urine cup device3,4 within the eReader™ drug screening system automatically tests, screens and reports results with no manual effort required to manipulate the device or capture results on a paper form, freeing up collectors’ time to focus on other value-added tasks that could potentially drive more revenue to your clinic.

Negative results5 are available within minutes through the MyeScreen™ portal, so your clients have the information they need to make same-day hiring decisions and maintain a productive workplace.​

TRANSFORM YOUR RAPID DRUG TESTING WITH eCUP+

When used with eScreen™ National Account clients, the average turnaround time (TAT) for negative drug test results with eCup+ is 15 minutes compared to 3 days for lab-based testing.5

EXPERIENCE THE eCUP+ DIFFERENCE TODAY​

EFFICIENT

Instrument-read technology to test, screen and report results – the collector is not interpreting the result​

OPTIMIZED

Only one device list number for easier inventory management​

FLEXIBLE

Over 100 panel configurations that test for 13 relevant drugs of abuse and match to hundreds of lab panels, including options with and without THC

FAST

Negative results in minutes as compared to days with lab-based testing and reported automatically through our MyeScreen portal​

BOOST CLINIC WORKFLOW AND ACCELERATE CLIENT HIRING WITH eCUP+
LEARN MORE ABOUT HOW TO BECOME A CLINIC PARTNER FOR COLLECTIONS

REFERENCES AND DISCLAMERS

1. Tsai, J, Bond, G. A Comparison of Electronic Records to Paper Records in Mental Health Centers. Int. J. Qual. Health Care, Vol 20-2, Apr 2008, 136–143.

2. Heaton, J. (2024, December 11). The Hidden Costs of Paper-Based Records: Why EHR Adoption Is No Longer Optional. Chart Logic. https://www.chartlogic.com/blog/hidden-costs-of-paper-based-records-why-ehr-adoption-is-no-longer-optional/ (Accessed 2025, June 18).

3. Drug testing regulations vary state by state. Use of rapid point-of-collection testing (POCT) may be prohibited based on specific testing parameters. Consult your state-level regulations for guidance on whether use of rapid POCT devices for employment screening is permitted in your state. ​

4. The eReader™+ drug testing system with eCup™+ urine cup device is intended for employment and insurance testing only.​

5. Non-negative samples are sent to the laboratory for confirmatory testing, and then to an independent medical review officer (MRO) for final determination.​

6. Based on 2024 data on file at Abbott.​

Employers | Collection Sites | About | Resources | Careers | Interest-Based Ads

©2025 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our
Website Terms and Conditions, Privacy Policy, and Consumer Health Data Privacy Policy.